These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 17351667)

  • 21. Metformin improves the angiogenic functions of endothelial progenitor cells via activating AMPK/eNOS pathway in diabetic mice.
    Yu JW; Deng YP; Han X; Ren GF; Cai J; Jiang GJ
    Cardiovasc Diabetol; 2016 Jun; 15():88. PubMed ID: 27316923
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effective treatment of vascular endothelial growth factor refractory hindlimb ischemia by a mutant endothelial nitric oxide synthase gene.
    Qian HS; Liu P; Huw LY; Orme A; Halks-Miller M; Hill SM; Jin F; Kretschmer P; Blasko E; Cashion L; Szymanski P; Vergona R; Harkins R; Yu J; Sessa WC; Dole WP; Rubanyi GM; Kauser K
    Gene Ther; 2006 Sep; 13(18):1342-50. PubMed ID: 16642030
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rivaroxaban, a factor Xa inhibitor, improves neovascularization in the ischemic hindlimb of streptozotocin-induced diabetic mice.
    Wu TC; Chan JS; Lee CY; Leu HB; Huang PH; Chen JS; Lin SJ; Chen JW
    Cardiovasc Diabetol; 2015 Jun; 14():81. PubMed ID: 26077117
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sustained delivery of sphingosine-1-phosphate using poly(lactic-co-glycolic acid)-based microparticles stimulates Akt/ERK-eNOS mediated angiogenesis and vascular maturation restoring blood flow in ischemic limbs of mice.
    Qi X; Okamoto Y; Murakawa T; Wang F; Oyama O; Ohkawa R; Yoshioka K; Du W; Sugimoto N; Yatomi Y; Takuwa N; Takuwa Y
    Eur J Pharmacol; 2010 May; 634(1-3):121-31. PubMed ID: 20206620
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Statin potentiates human platelet eNOS activity without enhancing eNOS mRNA and protein levels.
    Yemisci M; Ay H; Kocaefe C; Qui J; Topalkara K; Ozgüç M; Kirazli S; Ozcebe O; Moskowitz MA; Dalkara T
    Cerebrovasc Dis; 2008; 26(2):190-8. PubMed ID: 18628618
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angiogenic peptides improve blood flow and promote capillary growth in a diabetic and ischaemic mouse model.
    Raiter A; Bechor Z; Kleiman M; Leshem-Lev D; Battler A; Hardy B
    Eur J Vasc Endovasc Surg; 2010 Sep; 40(3):381-8. PubMed ID: 20226697
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular mechanism of limbs' postischemic revascularization improved by perindopril in diabetic rats.
    Gao L; Yu DM
    Chin Med J (Engl); 2008 Nov; 121(21):2129-33. PubMed ID: 19080171
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glycaemic variability affects ischaemia-induced angiogenesis in diabetic mice.
    Biscetti F; Pitocco D; Straface G; Zaccardi F; de Cristofaro R; Rizzo P; Lancellotti S; Arena V; Stigliano E; Musella T; Ghirlanda G; Flex A
    Clin Sci (Lond); 2011 Dec; 121(12):555-64. PubMed ID: 21729007
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decreased mobilization of endothelial progenitor cells contributes to impaired neovascularization in diabetes.
    Kang L; Chen Q; Wang L; Gao L; Meng K; Chen J; Ferro A; Xu B
    Clin Exp Pharmacol Physiol; 2009 Oct; 36(10):e47-56. PubMed ID: 19558529
    [TBL] [Abstract][Full Text] [Related]  

  • 30. BuZangTongLuo decoction improved hindlimb ischemia by activating angiogenesis and regulating gut microbiota in diabetic mice.
    Zheng J; Chen M; Ye C; Sun X; Jiang N; Zou X; Yang H; Liu H
    J Ethnopharmacol; 2020 Feb; 248():112330. PubMed ID: 31654796
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nanoparticle-mediated delivery of pioglitazone enhances therapeutic neovascularization in a murine model of hindlimb ischemia.
    Nagahama R; Matoba T; Nakano K; Kim-Mitsuyama S; Sunagawa K; Egashira K
    Arterioscler Thromb Vasc Biol; 2012 Oct; 32(10):2427-34. PubMed ID: 22879581
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Angiopoietin-related growth factor enhances blood flow via activation of the ERK1/2-eNOS-NO pathway in a mouse hind-limb ischemia model.
    Urano T; Ito Y; Akao M; Sawa T; Miyata K; Tabata M; Morisada T; Hato T; Yano M; Kadomatsu T; Yasunaga K; Shibata R; Murohara T; Akaike T; Tanihara H; Suda T; Oike Y
    Arterioscler Thromb Vasc Biol; 2008 May; 28(5):827-34. PubMed ID: 18258819
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Angiopoietin-1 gene transfer improves impaired wound healing in genetically diabetic mice without increasing VEGF expression.
    Bitto A; Minutoli L; Galeano MR; Altavilla D; Polito F; Fiumara T; Calò M; Lo Cascio P; Zentilin L; Giacca M; Squadrito F
    Clin Sci (Lond); 2008 Jun; 114(12):707-18. PubMed ID: 18078386
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pravastatin limits radiation-induced vascular dysfunction in the skin.
    Holler V; Buard V; Gaugler MH; Guipaud O; Baudelin C; Sache A; Perez Mdel R; Squiban C; Tamarat R; Milliat F; Benderitter M
    J Invest Dermatol; 2009 May; 129(5):1280-91. PubMed ID: 19212344
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ursolic acid induces allograft inflammatory factor-1 expression via a nitric oxide-related mechanism and increases neovascularization.
    Lee AW; Chen TL; Shih CM; Huang CY; Tsao NW; Chang NC; Chen YH; Fong TH; Lin FY
    J Agric Food Chem; 2010 Dec; 58(24):12941-9. PubMed ID: 21070071
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pioglitazone ameliorates endothelial dysfunction and restores ischemia-induced angiogenesis in diabetic mice.
    Huang PH; Sata M; Nishimatsu H; Sumi M; Hirata Y; Nagai R
    Biomed Pharmacother; 2008 Jan; 62(1):46-52. PubMed ID: 17692499
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pravastatin reverses obesity-induced dysfunction of induced pluripotent stem cell-derived endothelial cells via a nitric oxide-dependent mechanism.
    Gu M; Mordwinkin NM; Kooreman NG; Lee J; Wu H; Hu S; Churko JM; Diecke S; Burridge PW; He C; Barron FE; Ong SG; Gold JD; Wu JC
    Eur Heart J; 2015 Apr; 36(13):806-16. PubMed ID: 25368203
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The 3-hydroxy-3-methylglutaryl-CoA reductase inhibitor pravastatin reduces disease activity and inflammation in dextran-sulfate induced colitis.
    Sasaki M; Bharwani S; Jordan P; Joh T; Manas K; Warren A; Harada H; Carter P; Elrod JW; Wolcott M; Grisham MB; Alexander JS
    J Pharmacol Exp Ther; 2003 Apr; 305(1):78-85. PubMed ID: 12649355
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Simvastatin increases circulating endothelial progenitor cells and reduces the formation and progression of diabetic retinopathy in rats.
    Zhang W; Yan H
    Exp Eye Res; 2012 Dec; 105():1-8. PubMed ID: 23059402
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Comparative study of retinopathy in C57BL/6 and eNOS-knockout mouse models of type 1 diabetes mellitus].
    Liu Y; Lin T; Lei B
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Dec; 32(12):1683-8. PubMed ID: 23268389
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.